274 related articles for article (PubMed ID: 21382896)
21. Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.
Ciliberti P; Schulze-Neick I; Giardini A
Future Cardiol; 2012 Mar; 8(2):271-84. PubMed ID: 22413985
[TBL] [Abstract][Full Text] [Related]
22. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
23. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
[TBL] [Abstract][Full Text] [Related]
24. Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
Rao RS; Singh S; Sharma BB; Agarwal VV; Singh V
Indian J Chest Dis Allied Sci; 2011; 53(2):81-5. PubMed ID: 21545068
[TBL] [Abstract][Full Text] [Related]
25. Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.
Hill KD; Tunks RD; Barker PC; Benjamin DK; Cohen-Wolkowiez M; Fleming GA; Laughon M; Li JS
Pediatr Crit Care Med; 2013 Jul; 14(6):593-600. PubMed ID: 23823195
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
28. Sildenafil reduces pulmonary vascular resistance in single ventricular physiology.
Mori H; Park IS; Yamagishi H; Nakamura M; Ishikawa S; Takigiku K; Yasukochi S; Nakayama T; Saji T; Nakanishi T
Int J Cardiol; 2016 Oct; 221():122-7. PubMed ID: 27400308
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
Sastry BK; Narasimhan C; Reddy NK; Raju BS
J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
31. Effect of Ambrisentan on Exercise Capacity in Adult Patients After the Fontan Procedure.
Cedars AM; Saef J; Peterson LR; Coggan AR; Novak EL; Kemp D; Ludbrook PA
Am J Cardiol; 2016 May; 117(9):1524-32. PubMed ID: 27063478
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.
Bocchi EA; Guimarães G; Mocelin A; Bacal F; Bellotti G; Ramires JF
Circulation; 2002 Aug; 106(9):1097-103. PubMed ID: 12196335
[TBL] [Abstract][Full Text] [Related]
33. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
[TBL] [Abstract][Full Text] [Related]
34. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
Jackson RM; Glassberg MK; Ramos CF; Bejarano PA; Butrous G; Gómez-Marín O
Lung; 2010 Apr; 188(2):115-23. PubMed ID: 20012639
[TBL] [Abstract][Full Text] [Related]
36. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
[TBL] [Abstract][Full Text] [Related]
37. Effects of sildenafil on cardiopulmonary responses during stress.
Stanopoulos I; Hatzichristou D; Tryfon S; Tzortzis V; Apostolidis A; Argyropoulou P
J Urol; 2003 Apr; 169(4):1417-21. PubMed ID: 12629375
[TBL] [Abstract][Full Text] [Related]
38. Exercise oscillatory ventilation in systolic heart failure: an indicator of impaired hemodynamic response to exercise.
Murphy RM; Shah RV; Malhotra R; Pappagianopoulos PP; Hough SS; Systrom DM; Semigran MJ; Lewis GD
Circulation; 2011 Sep; 124(13):1442-51. PubMed ID: 21875912
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial.
Arruda-Olson AM; Mahoney DW; Nehra A; Leckel M; Pellikka PA
JAMA; 2002 Feb; 287(6):719-25. PubMed ID: 11851538
[TBL] [Abstract][Full Text] [Related]
40. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
